Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-18.71%
Change (1 year)
Categories
Kinnate Biopharma (KNTE) - P/B ratio
P/B ratio as of June 2024 : 0.7845
According to Kinnate Biopharma's latest financial reports the company has a price-to-book ratio of 0.7845.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Kinnate Biopharma - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.7008 | -32.76% |
| 2022-12-31 | 1.04 | -52.46% |
| 2021-12-31 | 2.19 | -50.15% |
| 2020-12-31 | 4.40 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.38 | 76.26% | 🇺🇸 USA |